225 related articles for article (PubMed ID: 21928226)
1. Prolonged versus standard prednisolone therapy for initial episode of idiopathic nephrotic syndrome.
Mishra OP; Thakur N; Mishra RN; Prasad R
J Nephrol; 2012; 25(3):394-400. PubMed ID: 21928226
[TBL] [Abstract][Full Text] [Related]
2. Prolonged versus standard prednisolone therapy for initial episode of nephrotic syndrome.
Bagga A; Hari P; Srivastava RN
Pediatr Nephrol; 1999 Nov; 13(9):824-7. PubMed ID: 10603129
[TBL] [Abstract][Full Text] [Related]
3. Can we predict relapses in children with idiopathic steroid-sensitive nephrotic syndrome?
Mishra OP; Abhinay A; Mishra RN; Prasad R; Pohl M
J Trop Pediatr; 2013 Oct; 59(5):343-9. PubMed ID: 23619602
[TBL] [Abstract][Full Text] [Related]
4. Extending initial prednisolone treatment in a randomized control trial from 3 to 6 months did not significantly influence the course of illness in children with steroid-sensitive nephrotic syndrome.
Sinha A; Saha A; Kumar M; Sharma S; Afzal K; Mehta A; Kalaivani M; Hari P; Bagga A
Kidney Int; 2015 Jan; 87(1):217-24. PubMed ID: 25029428
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of low-dose daily versus alternate-day prednisolone in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
Yadav M; Sinha A; Khandelwal P; Hari P; Bagga A
Pediatr Nephrol; 2019 May; 34(5):829-835. PubMed ID: 30194663
[TBL] [Abstract][Full Text] [Related]
6. Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial.
Hoyer PF; Brodeh J
J Am Soc Nephrol; 2006 Apr; 17(4):1151-7. PubMed ID: 16540560
[TBL] [Abstract][Full Text] [Related]
7. [Standard versus long-term prednisolone with sairei-to for initial therapy in childhood steroid-responsive nephrotic syndrome: a prospective controlled study].
Yoshikawa N; Ito H; Takekoshi Y; Honda M; Awazu M; Iijima K; Nakamura H; Seino Y; Takeda N; Hattori S; Matsuda I
Nihon Jinzo Gakkai Shi; 1998 Nov; 40(8):587-90. PubMed ID: 9893457
[TBL] [Abstract][Full Text] [Related]
8. Long-term steroid treatment and growth: a study in steroid-dependent nephrotic syndrome.
Simmonds J; Grundy N; Trompeter R; Tullus K
Arch Dis Child; 2010 Feb; 95(2):146-9. PubMed ID: 20172895
[TBL] [Abstract][Full Text] [Related]
9. Adrenocortical suppression increases the risk of relapse in nephrotic syndrome.
Abeyagunawardena AS; Hindmarsh P; Trompeter RS
Arch Dis Child; 2007 Jul; 92(7):585-8. PubMed ID: 17284479
[TBL] [Abstract][Full Text] [Related]
10. Body weight-based prednisolone versus body surface area-based prednisolone regimen for induction of remission in children with nephrotic syndrome: a randomized, open-label, equivalence clinical trial.
Raman V; Krishnamurthy S; Harichandrakumar KT
Pediatr Nephrol; 2016 Apr; 31(4):595-604. PubMed ID: 26759000
[TBL] [Abstract][Full Text] [Related]
11. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
Chen SY; Wu CY; Tsai IJ; Tsau YK
Nephrology (Carlton); 2010 Apr; 15(3):336-9. PubMed ID: 20470303
[TBL] [Abstract][Full Text] [Related]
12. Levamisole in steroid-sensitive nephrotic syndrome children with frequent relapses and/or steroid dependency: comparison of daily and every-other-day usage.
Fu LS; Shien CY; Chi CS
Nephron Clin Pract; 2004; 97(4):c137-41. PubMed ID: 15331936
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
Choudhry S; Bagga A; Hari P; Sharma S; Kalaivani M; Dinda A
Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
[TBL] [Abstract][Full Text] [Related]
14. Increasing the dose of prednisolone during viral infections reduces the risk of relapse in nephrotic syndrome: a randomised controlled trial.
Abeyagunawardena AS; Trompeter RS
Arch Dis Child; 2008 Mar; 93(3):226-8. PubMed ID: 17573408
[TBL] [Abstract][Full Text] [Related]
15. Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation.
Webb NJA; Woolley RL; Lambe T; Frew E; Brettell EA; Barsoum EN; Trompeter RS; Cummins C; Deeks JJ; Wheatley K; Ives NJ;
BMJ; 2019 May; 365():l1800. PubMed ID: 31335316
[TBL] [Abstract][Full Text] [Related]
16. Long versus standard initial prednisolone therapy in children with idiopathic nephrotic syndrome.
Paul SK; Muinuddin G; Jahan S; Begum A; Rahman MH; Hossain MM
Mymensingh Med J; 2014 Apr; 23(2):261-7. PubMed ID: 24858152
[TBL] [Abstract][Full Text] [Related]
17. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
Ehrich JH; Geerlings C; Zivicnjak M; Franke D; Geerlings H; Gellermann J
Nephrol Dial Transplant; 2007 Aug; 22(8):2183-93. PubMed ID: 17504846
[TBL] [Abstract][Full Text] [Related]
18. Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome.
Gulati A; Sinha A; Gupta A; Kanitkar M; Sreenivas V; Sharma J; Mantan M; Agarwal I; Dinda AK; Hari P; Bagga A
Kidney Int; 2012 Nov; 82(10):1130-5. PubMed ID: 22763815
[TBL] [Abstract][Full Text] [Related]
19. Levamisole in steroid dependent and frequently relapsing nephrotic syndrome.
Hafeez F; Ahmed TM; Samina U
J Coll Physicians Surg Pak; 2006 Jan; 16(1):35-7. PubMed ID: 16441986
[TBL] [Abstract][Full Text] [Related]
20. Predictors of relapse and long-term outcome in children with steroid-dependent nephrotic syndrome after rituximab treatment.
Fujinaga S; Hirano D; Mizutani A; Sakuraya K; Yamada A; Sakurai S; Shimizu T
Clin Exp Nephrol; 2017 Aug; 21(4):671-676. PubMed ID: 27558467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
